Clinical test data of 2.5 million people stolen from biotech company Enzo Biochem

An April ransomware attack on a biotech company resulted in the compromise of test information and personal data of nearly 2.5 million people, according to regulatory filings. Enzo Biochem, a New York-based biosciences and diagnostics company, said that on April 6 it experienced a ransomware attack that involved the “unauthorized access to or acquisition of

april attack biotech briefs compromise data information new york people personal personal data ransomware ransomware attack regulatory stolen test